Scott W. Baumgartner

Author

Also Known As

Nan Zhang, S W Baumgartner, S. W. Baumgartner, S.‐L. Lin, SCOTT W. BAUMGARTNER, Scott W Baumgartner, Scott W. Baumgartner

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)University of Colorado Denver Brigham and Women's Hospital Hospital for Special Surgery Mount Sinai Hospital

About

Scott W. Baumgartner is an author at Amgen (United States) specializing in inflammatory arthritis, inflammation, and immune regulation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	1.6K
2	Immunology	1	1	1.6K
3	Pathology	1	1	1.6K
4	Rheumatology	1	1	1.6K
5	Autoimmune Disease	1	1	1.6K

Scott W. Baumgartner

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein Larry W. Moreland, Scott W. Baumgartner, Michael Schiff, New England Journal of Medicine ImmunologyImmune RegulationPathologySoluble Tnf ReceptorImmune System	1997	1.6K
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis Daniel J. Lovell, Andreas Reiff, Norman T. Ilowite, Arthritis & Rheumatism	2008	317
Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis. Larry W. Moreland, S. Cohen, Scott W. Baumgartner, PubMed	2001	201
Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. Phillip J. Mease, Christopher T. Ritchlin, Richard W. Martin, PubMed	2004	156
Safety and efficacy of etanercept beyond 10 years of therapy in North American patients with early and longstanding rheumatoid arthritis Michael E. Weinblatt, Joan M. Bathon, Joel M. Kremer, Arthritis Care & Research	2010	102
Persistence with Anti-Tumor Necrosis Factor Therapies in Patients with Rheumatoid Arthritis: Observations from the RADIUS Registry Joseph A. Markenson, Allan Gibofsky, William Palmer, The Journal of Rheumatology	2011	95
Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results. Roy Fleischmann, Scott W. Baumgartner, Elizabeth A. Tindall, PubMed	2003	86
Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability. Scott W. Baumgartner, Roy Fleischmann, Larry W. Moreland, PubMed	2004	69
A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases Michael H. Weisman, Harold E. Paulus, Francis X. Burch, Lara D. Veeken	2007	65
Clinical trial safety and mortality analyses in patients receiving etanercept across approved indications. Alice B. Gottlieb, Kenneth Gordon, Edward H. Giannini, PubMed	2011	47

Page 1